• Home
  • About Us
    • Vision and Mission
    • Organization Structure
    • DRA Staff
    • Divisions
      • Registration Division
      • Inspection Division
      • Post Marketing Control Division
  • Publications
    • Acts
    • Rules and Regulations
    • Guidelines
    • Drafts
  • Forms
    • Administrative Forms
    • Application Forms
    • Drug Renewal Forms
    • Adverse Drug Reaction Form
  • List of Registered Drugs
  • Contact info
Login Register

Home

Notification to Market Authorization Holders.

  • Print
  • Email
Details
Published on Wednesday, 09 May 2012 13:33

All the Market Authorization Holders who have registered the medicines with the Authority are requested to check the validity status of the products registered.

As agreed by the medicine wholesalers in November 2011, the renewal with minimal documents will be considered for 3 months after expiry of registration. If the application for the renewal with specified documents is not submitted within specified time, the renewal will then be considered upon submission of all the documents as submitted during initial registration.

Furthermore, please note that as informed earlier, if the registration has expired after your products are imported into the country, they will be considered not valid and shall be treated as unregistered products.

This notification is issued for strict compliance by the Market Authorization Holders.

Chief Regulatory Officer

Registration Division, DRA

Draft Regulation for Blood and Blood Products

  • Print
  • Email
Details
Published on Wednesday, 09 May 2012 13:32

Draft Regulation for Blood and Blood Products As Human Blood and Blood Products, due to their therapeutic nature shall be declared as medicinal product by the Bhutan Medicines Board, its regulation becomes necessary under the Medicines Act of the Kingdom of Bhutan 2003, mandating Drug Regulatory Authority to institute a Regulation for the same.

Read more: Draft Regulation for Blood and Blood Products

Revised Bhutan Medicines Rules and Regulation 2012

  • Print
  • Email
Details
Published on Wednesday, 09 May 2012 13:33

Drug Regulatory Authority of Bhutan is pleased to announce that the revised Bhutan Medicines Rules and Regulations will be implemented from 1st  August 2012.

Prior to enforcement, sensitization on the revised and new sections will be carried out to all the stakeholders.

feed-image

Latest News

  • Adverse Drug Reaction Form
  • List of Banned Drugs
  • List of Wholesalers Operating in Bhutan
  • Draft Regulation for Blood and Blood Products
  • Revised Bhutan Medicines Rules and Regulation 2012
  • List of Wholesalers Operating in Bhutan
  • List of Banned Drugs

In-Country Weblinks

  • JDWNR Hospital
  • Ministry of Agriculture & Forest
  • Ministry Of Health
  • National Centre for Animal Heatlh

Referenced Drug Regulatory Authorites

  • European Medicines Agency
  • FDA, Thailand
  • FDA, United States
  • Heath Canada (HC)
  • HSA, Singapore
  • MHRA, United Kingdom
  • PMDA, Japan
  • TGA, Australia

Related International Organizations

  • Pharmaceutical Newsletter
  • PIC/S
  • World Health Organization
  • World Organization for Animal Health
Copyright © 2012. Drug Regulatory Authority .